This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

H5N1 Vaccine (SNY)


Drug Names(s): H5N1 (Avian Flu) Vaccine, Emerflu (EU)

Description: This is an inactivated vaccine made from an H5N1 virus isolated in Southeast Asia in 2004. Sanofi pasteur, formerly Aventis Pasteur, was awarded a contract by NIAID to manufacture the H5N1 vaccine in May 2004. It is a split virus, monovalent, unadjuvanted vaccine. The antigen is produced in infected chicken eggs.

H5N1 Vaccine (SNY) News

Pink Sheet Pandemic Flu

Pink Sheet Flu Update

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug